{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:52:02Z","timestamp":1791049922457,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.canlet.2008.12.004","type":"journal-article","created":{"date-parts":[[2009,1,13]],"date-time":"2009-01-13T09:35:20Z","timestamp":1231839320000},"page":"129-133","source":"Crossref","is-referenced-by-count":22,"title":["Innovative therapy for hepatocellular carcinoma: Three-dimensional high-dose photon radiotherapy"],"prefix":"10.1016","volume":"286","author":[{"given":"P.","family":"Merle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Mornex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Trepo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2005","key":"10.1016\/j.canlet.2008.12.004_bib1","first-page":"74","article-title":"Global cancer statistics","volume":"55","author":"Parkin","year":"2002","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2008.12.004_bib2","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJM199903113401001","article-title":"Rising incidence of hepatocellular carcinoma in the United States","volume":"340","author":"El-Serag","year":"1999","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.canlet.2008.12.004_bib3","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/hep.510290528","article-title":"Modeling the hepatitis C virus epidemic in France","volume":"29","author":"Deuffic","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2008.12.004_bib4","doi-asserted-by":"crossref","first-page":"817","DOI":"10.7326\/0003-4819-139-10-200311180-00009","article-title":"The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update","volume":"139","author":"El-Serag","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.canlet.2008.12.004_bib5","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/ije\/dyg101","article-title":"Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001","volume":"32","author":"Law","year":"2003","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.canlet.2008.12.004_bib6","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2217::AID-CNCR6>3.0.CO;2-M","article-title":"Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival","volume":"77","author":"Stuart","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2008.12.004_bib7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0168-8278(99)80173-1","article-title":"A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d\u2019Etude et de Traitement du Carcinome Hepatocellulaire","volume":"31","author":"Chevret","year":"1999","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2008.12.004_bib8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2214\/ajr.117.1.73","article-title":"Radiation hepatitis induced by abdominal irradiation with the cobalt 60 moving strip technique","volume":"117","author":"Wharton","year":"1973","journal-title":"Am. J. Roentgenol."},{"key":"10.1016\/j.canlet.2008.12.004_bib9","first-page":"21","article-title":"Human radiation hepatitis. A morphologic study with emphasis on the late change","volume":"96","author":"Lewin","year":"1973","journal-title":"Arch. Pathol."},{"key":"10.1016\/j.canlet.2008.12.004_bib10","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/0360-3016(94)00418-K","article-title":"Hepatic toxicity resulting from cancer treatment","volume":"31","author":"Lawrence","year":"1995","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canlet.2008.12.004_bib11","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1002\/cncr.21811","article-title":"Radiation therapy for hepatocellular carcinoma: from palliation to cure","volume":"106","author":"Hawkins","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2008.12.004_bib12","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/0360-3016(90)90031-E","article-title":"An application of dose volume histograms to the treatment of intrahepatic malignancies with radiation therapy","volume":"19","author":"Lawrence","year":"1990","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canlet.2008.12.004_bib13","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/0360-3016(92)90651-W","article-title":"The use of 3-D dose volume analysis to predict radiation hepatitis","volume":"23","author":"Lawrence","year":"1992","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canlet.2008.12.004_bib14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00000658-199304000-00009","article-title":"Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years","volume":"217","author":"Nagasue","year":"1993","journal-title":"Ann. Surg."},{"key":"10.1016\/j.canlet.2008.12.004_bib15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/hep.1840200205","article-title":"Postoperative adjuvant hepatic arterial infusion of lipiodol containing anticancer drugs in patients with hepatocellular carcinoma","volume":"20","author":"Izumi","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2008.12.004_bib16","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/00000658-199906000-00005","article-title":"An analysis of 412 cases of hepatocellular carcinoma at a Western center","volume":"229","author":"Fong","year":"1999","journal-title":"Ann. Surg."},{"key":"10.1016\/j.canlet.2008.12.004_bib17","first-page":"194","article-title":"The effect of percutaneous ethanol injection therapy on small solitary hepatocellular carcinoma is comparable to that of hepatectomy","volume":"89","author":"Kotoh","year":"1994","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.canlet.2008.12.004_bib18","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.canlet.2008.12.004_bib19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00000658-200009000-00010","article-title":"Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis","volume":"232","author":"Curley","year":"2000","journal-title":"Ann. Surg."},{"key":"10.1016\/j.canlet.2008.12.004_bib20","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S1470-2045(04)01567-0","article-title":"Radiofrequency ablation of liver tumors: systematic review","volume":"5","author":"Decadt","year":"2004","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2008.12.004_bib21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/01.SLA.0000048443.71734.BF","article-title":"Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future","volume":"237","author":"Lau","year":"2003","journal-title":"Ann. Surg."},{"key":"10.1016\/j.canlet.2008.12.004_bib22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00000658-200007000-00003","article-title":"Risk factors, prevention and management of postoperative recurrence after resection of hepatocellular carcinoma","volume":"232","author":"Tung-Ping","year":"2000","journal-title":"Ann. Surg."},{"key":"10.1016\/j.canlet.2008.12.004_bib23","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/01.SLA.0000059988.22416.F2","article-title":"Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence","volume":"237","author":"Ercolani","year":"2003","journal-title":"Ann. Surg."},{"key":"10.1016\/j.canlet.2008.12.004_bib24","first-page":"8","article-title":"Management of hepatocellular carcinoma","volume":"3","author":"Yu","year":"2003","journal-title":"Rev. Gastroenterol. Disord."},{"key":"10.1016\/j.canlet.2008.12.004_bib25","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S1470-2045(02)00873-2","article-title":"Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials","volume":"3","author":"Schwartz","year":"2002","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2008.12.004_bib26","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0168-8278(02)00360-4","article-title":"Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy","volume":"38","author":"Imamura","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2008.12.004_bib27","unstructured":"J. Llovet, S. Ricci, V. Mazzaferro, P. Hilgard, J. Raoul, S. Zeuzem, et al., Sorafenib improves survival in advanced hepatocellular carcinoma (HCC): results of a Phase III randomized placebo-controlled trial (SHARP trial), ASCO 2007 Annual Meeting, 2007."},{"key":"10.1016\/j.canlet.2008.12.004_bib28","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1200\/JCO.1993.11.7.1286","article-title":"Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy","volume":"11","author":"Robertson","year":"1993","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2008.12.004_bib29","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1200\/JCO.2000.18.11.2210","article-title":"Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies","volume":"18","author":"Dawson","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2008.12.004_bib30","doi-asserted-by":"crossref","first-page":"8739","DOI":"10.1200\/JCO.2005.01.5354","article-title":"Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies","volume":"23","author":"Ben-Josef","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2008.12.004_bib31","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0360-3016(02)02864-X","article-title":"Dose-response relationship in local radiotherapy for hepatocellular carcinoma","volume":"54","author":"Park","year":"2002","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canlet.2008.12.004_bib32","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/jjco\/hyh089","article-title":"Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolization","volume":"34","author":"Liu","year":"2004","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2008.12.004_bib33","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/01.coc.0000239147.60196.11","article-title":"Three-dimensional conformal radiotherapy of unresectable hepatocellular carcinoma patients for whom transcatheter arterial chemoembolization was ineffective or unsuitable","volume":"29","author":"Kim","year":"2006","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2008.12.004_bib34","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/jjco\/hyi236","article-title":"Fractionated stereotactic radiotherapy in patients with primary hepatocellular carcinoma","volume":"36","author":"Choi","year":"2006","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2008.12.004_bib35","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.canrad.2005.09.007","article-title":"Tolerance and efficacy of conformal radiotherapy for hepatocellular carcinoma in the cirrhotic patient. Results of the French RTF-1 trial","volume":"9","author":"Mornex","year":"2005","journal-title":"Cancer Radiother."},{"key":"10.1016\/j.canlet.2008.12.004_bib36","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.ijrobp.2006.06.015","article-title":"Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients wit small-size hepatocellular carcinoma noneligible for curative therapies \u2013 mature results of the French phase-II RTF-1 trial","volume":"66","author":"Mornex","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canlet.2008.12.004_bib37","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2008.12.004_bib38","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0360-3016(98)00415-5","article-title":"Combined transcathter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma","volume":"43","author":"Seong","year":"1999","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canlet.2008.12.004_bib39","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.3748\/wjg.v9.i8.1697","article-title":"Comparison between chemoembolization combined with radiotherapy and chemoembolization alone for large hepatocellular carcinoma","volume":"9","author":"Guo","year":"2003","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.canlet.2008.12.004_bib40","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/j.1478-3231.2005.01170.x","article-title":"Local radiotherapy as a complement to incomplete transcatheter arterial chemoembolization in locally advanced hepatocellular carcinoma","volume":"25","author":"Shim","year":"2005","journal-title":"Liver Int."},{"key":"10.1016\/j.canlet.2008.12.004_bib41","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1259\/bjr.73.874.11271902","article-title":"Evaluation of combined therapy with chemoembolization and irradiation for large hepatocellular carcinoma","volume":"73","author":"Guo","year":"2000","journal-title":"Brit. J. Radiol."},{"key":"10.1016\/j.canlet.2008.12.004_bib42","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.3748\/wjg.v10.i15.2184","article-title":"Therapeutic effects and prognostic factors in three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma","volume":"10","author":"Wu","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.canlet.2008.12.004_bib43","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1872-034X.2007.00084.x","article-title":"Hypofractionated stereotactic radiotherapy with and without transarterial chemoembolization for small hepatocellular carcinoma not eligible for other ablation therapies: preliminary results for efficacy and toxicity","volume":"38","author":"Takeda","year":"2008","journal-title":"Hepatol. Res."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383508009385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383508009385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T05:57:11Z","timestamp":1558072631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383508009385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0304383508009385"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2008.12.004","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}